Demographical and Clinical Characteristics of Inflammatory Bowel Disease Among Syrian Patients: A Retrospective Single-Centered Study
This retrospective single-centered study of 130 Syrian patients characterizes the demographic and clinical features of inflammatory bowel disease, revealing a 1.5:1 ulcerative colitis-to-Crohn's disease ratio with a blend of regional and Western phenotypic traits that underscores the necessity of regional research for personalized treatment.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the human body, the digestive tract is a long, continuous tube designed to break down food and absorb nutrients. Sometimes, however, the immune system mistakenly attacks this lining, causing chronic inflammation that leads to pain, bleeding, and difficulty digesting food. This condition is known as inflammatory bowel disease, a term that covers two main types: ulcerative colitis and Crohn's disease. While they share the same root cause, they behave differently. One type usually affects only the innermost lining of the colon, while the other can strike any part of the digestive tract and often penetrates deeper into the tissue. Because these diseases manifest differently in different parts of the world, doctors have long suspected that geography, genetics, and environment shape how they appear. Understanding these local variations is crucial, as it helps physicians choose the right treatment for the right patient, but for decades, a significant gap in knowledge remained regarding how these diseases affect people in Syria.
A team of researchers from the Syrian Private University and Ibn Al-Nafees Hospital set out to fill this void by looking back at the medical records of patients who had already been diagnosed. They gathered data on 130 individuals who had visited the hospital's specialized clinic between 2010 and 2026. To ensure their findings were as accurate as possible, the team did not rely solely on paper files, which were often incomplete. They reached out to patients by phone to ask specific questions about their family history and the symptoms they experienced when the disease first appeared. This effort allowed them to build a clearer picture of what inflammatory bowel disease looks like in the Syrian population, revealing a profile that is a unique blend of regional and Western characteristics.
The study found that ulcerative colitis was slightly more common than Crohn's disease, with a ratio of roughly one and a half cases of the former for every one case of the latter. The patients were diverse in age, but the average age when symptoms first appeared was around 32 years old for both conditions. When the disease began, the most common complaints were abdominal pain and the passage of blood in the stool. However, the specific mix of symptoms helped doctors distinguish between the two types. Patients with Crohn's disease were more likely to report significant weight loss and mucus in their stool, while those with ulcerative colitis were far more likely to experience frequent bloody bowel movements. Interestingly, the most common complication outside the gut was joint pain, which occurred more frequently in those with Crohn's disease.
When the researchers examined the physical state of the intestines using endoscopy, which involves looking inside the body with a camera, distinct patterns emerged. In ulcerative colitis, the tissue appeared red, swollen, and fragile, often bleeding easily when touched. In Crohn's disease, the researchers frequently saw narrowings or blockages in the intestine, a sign that the inflammation had caused the tissue to thicken and scar. Under the microscope, the tissue samples told an even more definitive story. The presence of tiny clusters of immune cells, known as granulomas, was found exclusively in patients with Crohn's disease and never in those with ulcerative colitis. This specific finding serves as a clear marker to separate the two conditions.
The study also mapped out where the disease struck and how it behaved. For Crohn's disease, the inflammation was most often found in the colon or in both the small and large intestines, and it typically presented as an active, inflamed state rather than a scarred or penetrating one. For ulcerative colitis, the disease most commonly affected the left side of the colon. Despite the severity of the symptoms and the high inflammation scores recorded at the time of diagnosis, the need for surgery was surprisingly low. Only about one in ten patients required an operation, with the vast majority of those needing surgery being the Crohn's disease patients. This low rate of surgical intervention suggests that in this region, doctors and patients may prefer to manage the disease with medication for as long as possible, reserving surgery as a last resort.
Ultimately, this research highlights that inflammatory bowel disease in Syria does not fit neatly into a single category. It shares some traits with patterns seen in Western countries, such as the age of onset and the specific types of inflammation, while also showing unique regional differences in how often surgery is needed and how the disease spreads. The authors note that because this study was conducted at a single hospital, the results might not represent every patient in the country, but they provide a vital first step. By documenting these local characteristics, the study offers a foundation for better diagnosis and more personalized care, ensuring that patients in Syria receive treatment plans tailored to the specific way their disease behaves.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.